Developmental Expression of a Candidate Müllerian Inhibiting Substance Type II Receptor

Endocrinology

Volumn 137, Issue 1, 1996, Pages 160-165

  Teixeira, Jose ^a,b   He, Wei Wu ^a   Shah, Paresh C ^a   Morikawa, Nobuyuki ^a   Lee, Mary M ^a   Catlin, Elizabeth A ^a   Hudson, Peter L ^a   Wing, John ^a   Maclaughlin, David T ^a   Donahoe, Patricia K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Massachusetts General Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; GROWTH REGULATION; IN SITU HYBRIDIZATION; MESENCHYME CELL; MUELLERIAN DUCT; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SEMINIFEROUS TUBULE; SEXUAL MATURATION; TISSUE DISTRIBUTION;

AGING; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; BLOTTING, NORTHERN; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FETUS; IN SITU HYBRIDIZATION; MALE; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, PEPTIDE;

EID: 1542400445     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.1.8536608     Document Type: Article

References (35)

1. Jost A 1947 Recherches sur la différenciation sexuelle de l'embryon de lapin. Arch Anat Micro Morph Exp 36:271-315
2. Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey AZ, Gash DJ, Chow EP, Fisher RA, Bertonis JM, Torres G, Wallner BP, Ramachandran KL, Ragin RC, Manganaro TF, MacLaughlin DT, Donahoe PK 1986 Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 45:685-698
3. MacLaughlin DT, Hudson PL, Graciano AL, Kenneally MK, Ragin RC, Manganaro TF, Donahoe PK 1992 Müllerian duct regression and antiproliferative bioactivities of Müllerian inhibiting substance reside in its carboxy-terminal domain. Endocrinology 131:291-296
4. Pepinsky RB, Sinclair LK, Chow EP, Mattaliano RJ, Manganaro TF, Donahoe PK, Cate RL 1989 Proteolytic processing of Müllerian inhibiting substance produces a transforming growth factor-beta-like fragment. J Biol Chem 263:18961-18964
5. Vigier B, Watrin F, Magre S, Tran D, Garrigou O, Forest MG, Josso N 1988 Anti-mullerian hormone and freemartinism: inhibition of germ cell development and induction of seminiferous cord-like structures in rat fetal ovaries exposed in vitro to purified bovine AMH. Reprod Nutr Dev 28:1113-1128; erratum in Reprod Nutr Dev 1988 [Suppl 1] 28:199
6. Lee MM, Donahoe PK 1993 Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 14:152-164
7. Wrana JL, Tran H, Attisano L, Arora K, Childs SR, Massague J, OConnor MB 1994 Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex. Mol Cell Biol 14:944-950
8. Wrana JL, Attisano L, Weiser R, Ventura F, Massagué J 1994 Mechanism of activation of the TGF-β receptor. Nature 370:341-347
9. He WW, Gustafson ML, Hirobe S, Donahoe PK 1993 Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family. Dev Dyn 196:133-142
10. Franzen P, ten DP, Ichijo H, Yamashita H, Schulz P, Heldin CH, Miyazono K 1993 Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 75:681-692
11. ten Dijke P, Ichijo H, Franzen P, Schulz P, Saras J, Toyoshima H, Heldin CH, Miyazono K 1993 Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8:2879-2887
12. Bassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe PK, Wang XF 1994 A transforming growth factor beta type I receptor that signals to activate gene expression. Science 263:87-89
13. Derynck R 1994 TGF-β receptor mediated signaling. Trends Biochem Sci 19:548-553
14. Baarends WM, van Helmond MJL, M, P, van der Schoot PJCM, Hoogerbrugge JW, de Winter JP, Uilenbroek JTJ, Karels B, Wilming LG, Meijers JHC, Themmen APN, Grootegoed JA 1994 A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Müllerian duct. Development 120: 189-197
15. di Clemente N, Wilson C, Faure E, Boussin L, Carmillo P, Tizard R, Picard J-Y, Vigier B, Josso N, Cate R 1994 Cloning, expression and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol 8:1006-1020
16. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning: A Laboratory Manual, ed. 2.Cold Spring Harbor Laboratory, New York
17. Sanger F, Nicklen S, Coulson AR 1977 DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 76:5463-5467
18. Ragin RC, Donahoe PK, Kenneally MK, Ahmad MF, MacLaughlin DT 1992 Human Müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects. Protein Expr Purif 3:236-245
19. Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA, Lodish HF 1992 Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785
20. Donaldson CJ, Mathews LS, Vale WW 1992 Molecular cloning and binding properties of the human type II activin receptor. Biochem Biophys Res Commun 184:310-316
21. Attisano L, Wrana JL, Chelfetz S, Massagué J 1992 Novel activin receptors: distinct genes and alternative mRNA splicing generate a repetoire of serine/threonine kinase receptors. Cell 68:97-108
22. Hirobe S, He WW, Lee MM, Donahoe PK 1992 Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity. Endocrinology 131: 854-862
23. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299
24. Massagué J, Attisano L, Wrana JL 1994 The TGF-β family and its composite receptors. Trends Cell Biol 4:172-178
25. Mathews LS, Vale WW, Kintner CR 1992 Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. Science 255:1702-1705
26. ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K, Heldin CH 1994 Characterization of type I receptors for transforming growth factor-beta and activin. Science 264:101-104
27. Harlow E, Lane D 1988 Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, New York
28. Daopin S, Piez KA, Ogawa Y, Davies DR 1992 Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily. Science 257:369-373
29. Rodbard D 1973 Mathematics of hormone-receptor interactions I Basic Principles. In: BW O'Malley, AR Means (eds) Advances in Experimental Biology, Medicine. Plenum Press, New York, pp 289-326
30. Haqq CM, King C-Y, Ukiyama E, Falsafi S, Haqq TN, Donahoe PK, Weiss MA 1994 Molecular basis of mammalian sexual determination: activation of Müllerian inhibiting substance gene expression by SRY. Science 266:1494-1500
31. Donahoe PK, Ito Y, Hendren WH 1977 A graded organ culture assay for the detection of Mullerian inhibiting substance. J Surg Res 23:141-148
32. Wang T, Donahoe PK, Zervos AS 1994 Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science 265:674-676
33. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257-261
34. de Groot RP, Kruijer W 1990 Transcriptional activation by TGFβ1 mediated by the dyad symmetry element (DSE) and the TPA responsive element (TRE). Biochem Biophys Res Commun 168:1074-1081
35. Hanks SK, Quinn AM 1991 Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Methods Enzymol 200:38-62